AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2019

Jun 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2019-06-11

Reporting Person: Biller Scott (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-11	Common stock	M	7218	$2.3375	Acquired	33729	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-11	Stock option (right to buy)	$2.3375	M	7218	Disposed	2022-04-05	Common stock (7218.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	53059	Indirect

Footnotes

F1: Shares held by a trust, of which the reporting person is trustee and beneficiary.

F2: This option was granted on April 6, 2012 for the purchase of 63,636 shares of common stock. The option vests as to 25% of the shares upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013. The performance criteria for the second performance milestone were met on April 4, 2014, resulting in the vesting of the option as to 31,818 shares, and the remaining 15,909 shares vested on April 4, 2015.